Cas no 40334-96-1 (2,4-Dimethoxy-6-methylpyridine)
2,4-Dimethoxy-6-methylpyridine Chemical and Physical Properties
Names and Identifiers
-
- 2,4-dimethoxy-6-methylpyridine
- 40334-96-1
- 974-161-9
- DTXCID60115826
- QBA33496
- Pyridine, 2,4-dimethoxy-6-methyl-
- G82591
- SB53196
- DTXSID50193335
- SCHEMBL8894323
- 2,4-Dimethoxy-6-methylpyridine
-
- Inchi: 1S/C8H11NO2/c1-6-4-7(10-2)5-8(9-6)11-3/h4-5H,1-3H3
- InChI Key: ZSABPIJTTNPSGX-UHFFFAOYSA-N
- SMILES: O(C)C1C=C(N=C(C)C=1)OC
Computed Properties
- Exact Mass: 153.078978594g/mol
- Monoisotopic Mass: 153.078978594g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 2
- Complexity: 119
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.5
- Topological Polar Surface Area: 31.4?2
2,4-Dimethoxy-6-methylpyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1721650-100mg |
2,4-Dimethoxy-6-methylpyridine |
40334-96-1 | 98% | 100mg |
¥664.00 | 2024-05-15 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1721650-250mg |
2,4-Dimethoxy-6-methylpyridine |
40334-96-1 | 98% | 250mg |
¥950.00 | 2024-05-15 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1721650-1g |
2,4-Dimethoxy-6-methylpyridine |
40334-96-1 | 98% | 1g |
¥3228.00 | 2024-05-15 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1721650-5g |
2,4-Dimethoxy-6-methylpyridine |
40334-96-1 | 98% | 5g |
¥7490.00 | 2024-05-15 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1721650-10g |
2,4-Dimethoxy-6-methylpyridine |
40334-96-1 | 98% | 10g |
¥12036.00 | 2024-05-15 |
2,4-Dimethoxy-6-methylpyridine Related Literature
-
1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
Additional information on 2,4-Dimethoxy-6-methylpyridine
Recent Advances in the Study of 2,4-Dimethoxy-6-methylpyridine (CAS: 40334-96-1) in Chemical Biology and Pharmaceutical Research
2,4-Dimethoxy-6-methylpyridine (CAS: 40334-96-1) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its unique pyridine core with methoxy and methyl substituents, serves as a crucial intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential in drug discovery, particularly in the development of kinase inhibitors and antimicrobial agents. The compound's structural features make it an attractive scaffold for medicinal chemistry, enabling the design of novel therapeutics with improved efficacy and selectivity.
One of the most notable advancements in the study of 2,4-Dimethoxy-6-methylpyridine is its role in the synthesis of kinase inhibitors. Kinases are key regulators of cellular signaling pathways, and their dysregulation is implicated in numerous diseases, including cancer and inflammatory disorders. Researchers have leveraged the compound's pyridine core to develop potent and selective kinase inhibitors. For instance, a recent study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 2,4-Dimethoxy-6-methylpyridine exhibited high affinity for specific kinase targets, leading to promising preclinical results in cancer models. The study highlighted the compound's potential as a starting point for the development of next-generation kinase inhibitors.
In addition to its applications in kinase inhibitor development, 2,4-Dimethoxy-6-methylpyridine has also been investigated for its antimicrobial properties. A 2023 study in the European Journal of Medicinal Chemistry reported that certain derivatives of this compound displayed significant activity against multidrug-resistant bacterial strains. The researchers attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, a mechanism distinct from that of conventional antibiotics. These findings suggest that 2,4-Dimethoxy-6-methylpyridine could serve as a valuable scaffold for the design of novel antimicrobial agents, addressing the growing challenge of antibiotic resistance.
Another area of interest is the compound's potential in agrochemical research. Recent work has explored its use as a precursor for the synthesis of herbicides and plant growth regulators. The methoxy and methyl substituents on the pyridine ring provide opportunities for structural modifications, enabling the development of compounds with tailored biological activities. A study in the Journal of Agricultural and Food Chemistry demonstrated that derivatives of 2,4-Dimethoxy-6-methylpyridine exhibited herbicidal activity against a broad spectrum of weeds, with minimal toxicity to crops. This research underscores the compound's versatility and its potential to contribute to sustainable agricultural practices.
Despite these promising developments, challenges remain in the optimization of 2,4-Dimethoxy-6-methylpyridine-based compounds. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed to fully realize their therapeutic and agrochemical potential. Recent efforts have focused on structural optimization and formulation strategies to overcome these limitations. For example, a 2024 study in ACS Medicinal Chemistry Letters reported the successful modification of the compound's side chains to improve its pharmacokinetic properties, resulting in enhanced in vivo efficacy.
In conclusion, 2,4-Dimethoxy-6-methylpyridine (CAS: 40334-96-1) represents a promising scaffold in chemical biology and pharmaceutical research. Its applications span drug discovery, antimicrobial development, and agrochemical innovation, driven by its unique structural features and versatility. Ongoing research aims to further elucidate its mechanisms of action and optimize its derivatives for clinical and agricultural use. As the field advances, this compound is poised to play a pivotal role in addressing some of the most pressing challenges in medicine and agriculture.
40334-96-1 (2,4-Dimethoxy-6-methylpyridine) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)